CSF Detection via Sialo-Transferrin Oxidation

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for diagnosing cerebrospinal fluid (CSF) leaks post-surgery are time-consuming and inefficient, often requiring laboratory analysis via electrophoresis, which can take several days, making it challenging for spine surgeons to promptly identify and address CSF leaks, particularly in cases where differentiation from seromatous fluid is unclear.

Innovation Solution

A novel method involving the selective removal of sialo-transferrin from biological samples using an oxidizing agent and hydrazide reactive groups to detect the presence of CSF-derived asialo-transferrin, enabling rapid detection of CSF leaks through chemical or enzymatic oxidation and conjugation, followed by filtration and immunoassay analysis.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If electrophoresis is used to distinguish CSF from seromatous fluid, then diagnostic accuracy is improved, but diagnostic time increases to three to five days

Engineering Contradiction:
Improvediagnostic accuracyVSAvoiddiagnostic time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The diagnostic process is segmented into two stages: rapid screening using the colorimetric assay for immediate results, and confirmatory electrophoresis for definitive diagnosis. This segmentation allows clinicians to quickly identify suspected CSF leaks and initiate appropriate management while maintaining diagnostic rigor through subsequent confirmation.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The colorimetric assay performs preliminary detection of CSF in aspirated fluid before definitive electrophoresis analysis. By conducting this preliminary action, the system enables rapid triage of patients, allowing those with confirmed CSF leaks to receive prompt surgical intervention while avoiding unnecessary delays for patients with non-CSF collections.

Inventive Principle:
Principle #10Preliminary action

2Productivity

If rapid detection methods are implemented, then surgical intervention time is reduced, but detection reliability may be compromised

Engineering Contradiction:
Improvediagnostic speedVSAvoiddetection reliability
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The colorimetric assay serves as an intermediary screening tool between fluid aspiration and definitive electrophoresis analysis. It provides rapid preliminary results that guide immediate clinical decisions, while the gold standard electrophoresis remains available for confirmation, thus maintaining reliability while improving diagnostic throughput.

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The patent replaces the purely mechanical/electrical electrophoresis system with a chemical colorimetric detection system for preliminary screening. This substitution enables rapid visual or spectrophotometric detection of CSF without requiring complex electrophoresis equipment, thereby improving diagnostic speed while maintaining adequate reliability for initial assessment.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This method allows for quick and accurate identification of CSF leaks, facilitating timely surgical intervention and reducing the risk of complications such as meningitis by providing a rapid, real-time diagnostic tool for spine surgeons.

Implementation Method 1

adding an oxidizing agent to the sample in an amount sufficient to generate oxidized sialo-transferrin (sTF), wherein the oxidized sTF comprises an aldehyde group in a terminal residue

Methodology Applied
Scientific EffectOxidation: Oxidation

Implementation Method 2

contacting the sample obtained from step b with a reagent comprising hydrazide reactive groups wherein the oxidized sTF binds the hydrazide reactive groups to form a complex

Methodology Applied
Scientific EffectChemical Bonding: Chemical Bonding

Data Source

PatentUS11067581B2Detection of cerebrospinal fluid
Publication Date: 2021.07.20 NSPC TECH LLC
  • US11067581B2 patent drawing
  • US11067581B2 patent drawing
  • US11067581B2 patent drawing

AI summary

The invention encompasses methods and test strips for detecting the presence of cerebrospinal fluid (CSF) in a biological sample comprising removing sialo-transferrin and selectively detecting or measuring asialo-transferrin in the biological sample.